ow-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)
Phase 2
Completed
- Conditions
- Brain metastases
- Registration Number
- JPRN-UMIN000009055
- Lead Sponsor
- iigata University, Dept of Radiology, Japanese Radiation Oncology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) severe decline in neurocognitive function or language ability at baseline 2) history of brain radiation therapy 3) history of brain surgery of brain metastases 4) small cell carcinoma, germinoma, lymphoma 5) any other reasons not to fit to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development rate of distant brain metastases at 6-month after treatment
- Secondary Outcome Measures
Name Time Method 1) Neurocognitive function at 4-month 2) Neurocognitive function at 12-month 3) Local tumor control of brain metastases 4) Overall survival 5) Cause of death